MIKEL
TAINTA CUEZVA
South London and Maudsley NHS Foundation Trust
Londres, Reino UnidoSouth London and Maudsley NHS Foundation Trust-ko ikertzaileekin lankidetzan egindako argitalpenak (7)
2023
-
Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning
Genome Medicine, Vol. 15, Núm. 1
2022
2021
-
Sex-specific metabolic pathways were associated with alzheimer’s disease (Ad) endophenotypes in the european medical information framework for ad multimodal biomarker discovery cohort
Biomedicines, Vol. 9, Núm. 11
-
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels
Alzheimer's and Dementia, Vol. 17, Núm. 10, pp. 1628-1640
2020
-
Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology
Journal of Alzheimer's Disease, Vol. 77, Núm. 3, pp. 1353-1368
-
Genome-wide association study of Alzheimer’s disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset
Translational Psychiatry, Vol. 10, Núm. 1
2019
-
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay
Alzheimer's and Dementia, Vol. 15, Núm. 11, pp. 1478-1488